Four deaths and a funeral: From caspases to alternative mechanisms

Nature Reviews Molecular Cell Biology

Volumn 2, Issue 8, 2001, Pages 589-598

  Leist, Marcel ^a   Jäättelä, Marja ^b  

^a H LUNDBECK A S   (Denmark)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CYSTEINE PROTEINASE INHIBITOR; FAS ANTIGEN; FUNGAL PROTEIN; HELMINTH PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL; APOPTOSIS; CAENORHABDITIS ELEGANS; CHROMATIN; CYTOLOGY; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; EUKARYOTIC CELL; GROWTH, DEVELOPMENT AND AGING; HUMAN; MITOCHONDRION; MOLECULAR EVOLUTION; NECROSIS; NEOPLASM; NERVOUS SYSTEM; PATHOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT; REVIEW; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION; ULTRASTRUCTURE;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CAENORHABDITIS ELEGANS; CASPASES; CHROMATIN; CYSTEINE PROTEINASE INHIBITORS; ENZYME ACTIVATION; EUKARYOTIC CELLS; EVOLUTION, MOLECULAR; FUNGAL PROTEINS; HELMINTH PROTEINS; HUMANS; MITOCHONDRIA; NECROSIS; NEOPLASMS; NERVOUS SYSTEM; RECEPTORS, TUMOR NECROSIS FACTOR; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION;

EID: 0035433420     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/35085008     Document Type: Review

References (114)

1. Kerr, J. F. R., Wyllie, A. H. & Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257 (1972).
2. Hengartner, M. O. The biochemistry of apoptosis. Nature 407, 770-776 (2000).
3. Strasser, A., O'Connor, L. & Dixit, V. M. Apoptosis signaling. Annu. Rev. Biochem. 69, 217-245 (2000).
4. Wright, S. C. et al. Activation of CPP32-like proteases is not sufficient to trigger apoptosis: inhibition of apoptosis by agents that suppress activation of AP24, but not CPP32-like activity. J. Exp. Med. 186, 1107-1117 (1997).
5. Lacana, E., Ganjei, J. K., Vito, P. & D'Adamio, L. Dissociation of apoptosis and activation of IL-1β-converting enzyme/Ced-3 proteases by ALG-2 and the truncated Alzheimer's gene ALG-3. J. Immunol. 158, 5129-5135 (1997).
6. Jäättelä, M., Wissing, D., Kokholm, K., Kallunki, T. & Egeblad, M. Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases. EMBO J. 17, 6124-6134 (1998).
7. De Maria, R. et al. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature 401, 489-493 (1999).
8. Harvey, K. J., Lukovic, D. & Ucker, D. S. Caspase-dependent Cdk activity is a requisite effector of apoptotic death events. J. Cell Biol. 148, 59-72 (2000).
9. Foghsgaard, L. et al. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J. Cell Biol. 153, 999-1009 (2001). The first identification of a protease (cathepsin B) that mediates death-receptor-induced caspase-independent apoptosis-like PCD. The requirement of cathepsin B for phosphatidylserine exposure, blebbing and final execution in TNF-induced caspase-dependent death is also shown. Provides a table of specificity profiles for commonly used protease inhibitors.
10. Roberts, L. R., Adjei, P. N. & Gores, G. J. Cathepsins as effector proteases in hepatocyte apoptosis. Cell. Biochem. Biophys. 30, 71-88 (1999).
11. Lavoie, J. N., Nguyen, M., Marcellus, R. C., Branton, P. E. & Shore, G. C. E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk. J. Cell Biol. 140, 637-645 (1998).
12. - T cells. Proc. Natl Acad. Sci. USA 95, 12556-12561 (1998).
13. Borner, C. & Monney, L. Apoptosis without caspases: an inefficient molecular guillotine. Cell Death Differ. 6, 497-507 (1999).
14. Kitanaka, C. & Kuchino, Y. Caspase-independent programmed cell death with necrotic morphology. Cell Death Differ. 6, 508-515 (1999).
15. Mathiasen, I. S., Lademann, U. & Jäättelä, M. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53. Cancer Res. 59, 4848-4856 (1999).
16. Nylandsted, J. et al. Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. Proc. Natl Acad. Sci. USA 97, 7871-7876 (2000). The first demonstration of an endogenous protein (Hsp70) that is specifically required for the survival of tumorigenic cells. The transformation-associated death programme inhibited by Hsp70 is shown to be caspase independent.
17. Elliott, K., Ge, K., Du, W. & Prendergast, G. C. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program. Oncogene 19, 4669-4684 (2000).
18. Joza, N. et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410, 549-554 (2001). Gene deletion of Aif in mice. Genetic evidence for the essential role of AIF in developmental apoptosis.
19. Leist, M., Single, B., Castoldi, A. F., Kuhnle, S. & Nicotera, P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185, 1481-1486 (1997). Initial demonstration that initially similar cell-death signals are switched between apoptosis and programmed necrosis by metabolic conditions in the cell.
20. Vercammen, D. et al. Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J. Exp. Med. 188, 919-930 (1998). Demonstrates the ability of tumour necrosis factor receptor 1 and Fas to trigger caspase-independent programmed necrosis, mediated by the production of mitochondrial reactive oxygen species.
21. Leist, M. et al. Inhibition of mitochondrial ATP generation by nitric oxide switches apoptosis to necrosis. Exp. Cell Res. 249, 396-403 (1999).
22. Chung, S., Gumienny, T. L., Hengartner, M. O. & Driscoll, M. A common set of engulfment genes mediates removal of both apoptotic and necrotic cell corpses in C. elegans. Nature Cell Biol. 2, 931-937 (2000).
23. Hirt, U. A., Gantner, F. & Leist, M. Phagocytosis of nonapoptotic cells dying by caspase-independent mechanisms. J. Immunol. 164, 6520-6529 (2000). Shows that cells dying by different caspase-independent mechanisms can be recognized by phagocytes in various ways and can be efficiently ingested.
24. Aravind, L., Dixit, V. M. & Koonin, E. V. Apoptotic molecular machinery: vastly increased complexity in vertebrates revealed by genome comparisons. Science 291, 1279-1284 (2001).
25. Frohlich, K. U. & Madeo, F. Apoptosis in yeast - a monocellular organism exhibits altruistic behaviour. FEBS Lett. 473, 6-9 (2000).
26. Ameisen, J. C. The origin of programmed cell death. Science 272, 1278-1279 (1996).
27. Wyllie, A. H. & Golstein, P. More than one way to go. Proc. Natl Acad. Sci. USA 98, 11-13 (2001).
28. Ellis, H. M. & Horvitz, H. R. Genetic control of programmed cell death in nematode C. elegans. Cell 44, 817-829 (1986).
29. Los, M., Wesselborg, S. & Schulze-Osthoff, K. The role of caspases in development, immunity, and apoptotic signal transduction: lessons from knockout mice. Immunity 10, 629-639 (1999).
30. Nicotera, P., Leist, M. & Manzo, L. Neuronal cell death: a demise with different shapes. Trends Pharmacol. Sci. 20, 46-51 (1999).
31. Woodle, E. S. et al. Anti-human class I MHC antibodies induce apoptosis by a pathway that is distinct from the Fas antigen-mediated pathway. J. Immunol. 158, 2156-2164 (1997).
32. McCarthy, N. J., Whyte, M. K. B., Gilbert, C. S. & Evan, G. I. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J. Cell Biol. 136, 215-227 (1997). Shows that caspase activation functions as a general switch between necrosis and apoptosis, but is not required for death itself.
33. Mateo, V. et al. CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia. Nature Med. 5, 1277-1284 (1999).
34. Holler, N. et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nature Immunol. 1, 489-495 (2000). The first description of the requirement of RIP kinase activity for the death-receptor-induced necrotic pathway. Also indicates that programmed necrosis might be the dominant death mode induced by Fas in activated primary lymphocytes.
35. Schulze-Osthoff, K. et al. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J. Biol. Chem. 267, 5317-5323 (1992).
36. Ha, H. C. & Snyder, S. H. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc. Natl Acad. Sci. USA 96, 13978-13982 (1999).
37. Bursch, W. et al. Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Carcinogenesis 17, 1595-1607 (1996).
38. Chi, S. et al. Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells. Oncogene 18, 2281-2290 (1999).
39. Roach, H. I. & Clarke, N. M. Physiological cell death of chondrocytes in vivo is not confined to apoptosis. New observations on the mammalian growth plate. J. Bone Joint Surg. Br. 82, 601-613 (2000).
40. Turmaine, M. et al. Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. Proc. Natl Acad. Sci. USA 97, 8093-8097 (2000).
41. Deas, O. et al. Caspase-independent cell death induced by anti-CD2 or staurosporine in activated human peripheral T lymphocytes. J. Immunol. 161, 3375-3383 (1998).
42. Luschen, S., Ussat, S., Scherer, G., Kabelitz, D. & Adam-Klages, S. Sensitization to death receptor cytotoxicity by inhibition of FADD/caspase signaling: requirement of cell cycle progression. J. Biol. Chem. 275, 24670-24678 (2000).
43. Volbracht, C., Leist M., Kolb, S. A. & Nicotera, P. Apoptosis in caspase-inhibited neurons. Mol. Med. 7, 36-48 (2001).
44. Xue, L., Fletcher, G. C. & Tolkovsky, A. M. Autophagy is activated by apoptotic signalling in sympathetic neurons: an alternative mechanism of death execution. Mol. Cell Neurosci. 14, 180-198 (1999).
45. Xiang, J., Chao, D. T. & Korsmeyer, S. J. Bax-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc. Natl Acad. Sci. USA 93, 14559-14563 (1996). The first demonstration of caspase-independent programmed cell death induced by Bax-like molecules.
46. Khwaja, A. & Tatton, L. Resistance to the cytotoxic effects of tumor necrosis factor-α can be overcome by inhibition of a FADD/caspase-dependent signaling pathway. J. Biol. Chem. 274, 36817-36823 (1999).
47. Chautan, M., Chazai, G., Cecconi, F., Gruss, P. & Golstein, P. Interdigital cell death can occur through a necrotic and caspase-independent pathway. Curr. Biol. 9, 967-970 (1999).
48. Matsumura, H. et al. Necrotic death pathway in Fas receptor signaling. J. Cell Biol. 151, 1247-1256 (2000).
49. Amarante-Mendes, G. P. et al. Anti-apoptotic oncogenes prevent caspase-dependent and independent commitment for cell death. Cell Death Differ. 5, 298-306 (1998).
50. Chua, B. T., Guo, K. & Li, P. Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases. J. Biol. Chem. 275, 5131-5135 (2000).
51. Lankiewicz, S. et al. Activation of calpain I converts excitotoxic neuron death into a caspase-independent cell death, J. Biol. Chem. 275, 17064-17071 (2000).
52. Jäättelä, M. Escaping cell death: survival proteins in cancer. Exp. Cell Res. 248, 30-43 (1999).
53. Smith, K. G., Strasser, A. & Vaux, D. L. CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/ APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease. EMBO J. 15, 5167-5176 (1996).
54. Doerfler, P., Forbush, K. A. & Perlmutter, R. M. Caspase enzyme activity is not essential for apoptosis during thymocyte development. J. Immunol. 164, 4071-4079 (2000).
55. Kunstle, G. et al. Concanavalin A hepatotoxicity in mice: tumor necrosis factor-mediated organ failure independent of caspase-3-like protease activation. Hepatology 30, 1241-1251 (1999).
56. Savill, J. & Fadok, V. Corpse clearance defines the meaning of cell death. Nature 407, 784-788 (2000).
57. Wolf, B. B. et al. Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. Blood 94, 1683-1692 (1999).
58. Mattson, M. P. Apoptosis in neurodegenerative disorders. Nature Rev. Mol. Cell Biol. 1, 120-129 (2000).
59. Leverrier, Y. & Ridley, A. J. Apoptosis: caspases orchestrate the ROCK'n' bleb. Nature Cell Biol. 3, E91-E93 (2001).
60. Deiss, L. P., Galinka, H., Berissi, H., Cohen, O. & Kimchi, A. Catepsin D protease mediates programmed cell death induced by interferon-γ, Fas/APO-1 and TNF-α. EMBO J. 15, 3861-3870 (1996).
61. Guicciardi, M. E. et al. Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Invest. 106, 1127-1137 (2000).
62. Waterhouse, N. J. et al. Calpain activation is upstream of caspases in radiation-induced apoptosis. Cell Death Differ. 5, 1051-1061 (1998).
63. Vanags, D. M., Porn-Ares, M. I., Coppola, S., Burgess, D. H. & Orrenius, S. Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J. Biol. Chem. 271, 31075-31085 (1996).
64. Johnson, D. E. Noncaspase proteases in apoptosis. Leukemia 14, 1695-1703 (2000). A review that profoundly discusses different proteases and the technologies used to identify their contribution to cell death.
65. Leist, M. & Jäättelä, M. Triggering of apoptosis by cathepsins. Cell Death Differ. 8, 324-326 (2001).
66. Squier, M. K., Miller, A. C., Malkinson, A. M. & Cohen, J. J. Calpain activation in apoptosis. J. Cell Physiol. 159, 229-237 (1994).
67. Yamashima, T. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog. Neurobiol. 62, 273-295 (2000).
68. Wang, K. K. Calpain and caspase: can you tell the difference? Trends Neurosci. 23, 20-26 (2000).
69. Roberg, K. Relocalization of cathepsin D and cytochrome c early in apoptosis revealed by immunoelectron microscopy. Lab. Invest. 81, 149-158 (2001).
70. Schotte, P. Declercq, W., Van Huffei, S., Vandenabeele, P. & Beyaert, R. Non-specific effects of methyl ketone peptide inhibitors of caspases. FEBS Lett. 442, 117-121 (1999).
71. Laster, S. M., Wood, J. G. & Gooding, L. R. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J. Immunol. 141, 2629-2634 (1988).
72. Kawahara, A., Ohsawa, Y., Matsumura, H., Uchiyama, Y. & Nagata, S. Caspase-independent cell killing by Fas-associated protein with death domain. J. Cell Biol. 143, 1353-1360 (1998).
73. Yang, X., Koshravi-Far, R., Chang, H. Y. & Baltimore, D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89, 1067-1076 (1997).
74. Chang, H. Y., Nishitoh, H., Yang, X., Ichijo, H. & Baltimore, D. Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. Science 181, 1860-1863 (1998).
75. Tobiume, K. et al. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2, 222-228 (2001).
76. Tournier, C. et al. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288, 870-374 (2000).
77. Charette, S. J., Lavoie, J. N., Lambert, H. & Landry, J. Inhibition of Daxx-mediated apoptosis by heat shock protein 27. Mol. Cell. Biol. 20, 7602-7612 (2000).
78. Susin, S. A. et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397, 441-446 (1999). Cloning and cell biological characterization of the mitochondrial caspase-independent programmed cell death mediator AIF.
79. Suter, M. et al. Age-related macular degeneration. The lipofusion component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells. J. Biol. Chem. 275, 39625-39630 (2000).
80. Daugas, E. et al. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J. 14, 729-739 (2000).
81. Miller, T. M. et al. Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death. J. Cell Biol. 139, 205-217 (1997).
82. Hirsch, T. et al. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 15, 1573-1581 (1997).
83. Finn, J. T. et al. Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases. J. Neurosci. 20, 1333-1341 (2000).
84. Schierle, G. S. et al. Differential effects of Bcl-2 overexpression on fibre outgrowth and survival of embryonic dopaminergic neurons in intracerebral transplants. Eur. J. Neurosci. 11, 3073-3081 (1999).
85. Tamatani, M. et al. ORP150 protects against hypoxia/ischemia-induced neuronal death. Nature Med. 7, 317-323 (2001).
86. Schmitt, C. A. & Lowe, S. W. Apoptosis and therapy. J. Pathol. 187, 127-137 (1999).
87. Kerr, J. F. R., Winterford, C. M. & Harmon, B. V. Apoptosis. Its significance in cancer and cancer therapy. Cancer 73, 2013-2026 (1994).
88. Lavoie, J. N., Champagne, C., Gingras, M. C. & Robert, A. Adenovirus E4 open reading frame 4-induced apoptosis involves dysregulation of Src family kinases. J. Cell Biol. 150, 1037-1056 (2000).
89. Nylandsted, J., Brand, K. & Jäättelä, M. Heat shock protein 70 is required for the survival of cancer cells. Ann. NY Acad. Sci. 926, 122-125 (2000).
90. Duffy, M. J. Proteases as prognostic markers in cancer. Clin. Cancer Res. 2, 613-618 (1996).
91. Alexander, C. M., Howard, E. W., Bissell, M. J. & Werb, Z. Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene. J. Cell Biol. 135, 1669-1677 (1996).
92. Quignon, F. et al. PML induces a novel caspase-independent death process. Nature Genet. 20, 259-265 (1998). The first demonstration of a tumour-suppressor protein (PML) that activates a caspase-independent PCD.
93. Wang, Z. G. et al. PML is essential for multiple apoptotic pathways. Nature Genet. 20, 266-272 (1998).
94. Wang, Q., Yang, W., Uytingco, M. S., Christakos, S. & Wieder, R. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death. Cancer Res. 60, 2040-2048 (2000).
95. Mathiasen, I. S., Hansen, C. M., Foghsgaard, L. & Jäättelä, M. Sensitization to TNF-induced apoptosis by 1,25-dihydroxy vitamin D(3) involves up-regulation of the TNF receptor 1 and cathepsin B. Int. J. Cancer 93, 224-231 (2001).
96. Raff, M. C. Social controls on cell survival and cell death. Nature 356, 397-400 (1992).
97. Johnson, M. D., Kinoshita, Y., Xiang, H., Ghatan, S. & Morrison, R. S. Contribution of p53-dependent caspase activation to neuronal cell death declines with neuronal maturation. J. Neurosci. 19, 2996-3006 (1999).
98. Deshmukh, M., Kuida, K. & Johnson, E. M. Jr Caspase inhibition extends the commitment to neuronal death beyond cytochrome c retease to the point of mitochondrial depolarization. J. Cell Biol. 150, 131-143 (2000).
99. Stadelmann, C. et al. Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. Am. J. Pathol. 155, 1459-1466 (1999).
100. Hansson, O. et al. Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Proc. Natl Acad. Sci. USA 96, 8727-8732 (1999).
101. Yamamoto, A., Lucas, J. J. & Hen, R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 101, 57-66 (2000).
102. Jellinger K. A. & Stadelmann, C. H. The enigma of cell death in neurodegenerative disorders. J. Neural Transm. S21-S36 (2000).
103. Xue, L., Fletcher, G. C. & Tolkovsky, A. M. Mitochondria are selectively eliminated from eukaryotic cells after blockade of caspases during apoptosis. Curr. Biol. 11, 361-365 (2001).
104. Sperandio, S., de Belle, I. & Bredesen, D. E. An alternative, nonapoptotic form of programmed cell death. Proc. Natl Acad. Sci. USA 97, 14376-14381 (2000). Definition of paraptosis as a mode of neuronal death that is independent of caspase activity. Contains numerous references on alternative death modes.
105. Fujikawa, D. G. Confusion between neuronal apoptosis and activation of programmed cell death mechanisms in acute necrotic insults. Trends Neurosci. 23, 410-411 (2000).
106. Roy, M. & Sapolsky, R. Neuronal apoptosis in acute necrotic insults: why is this subject such a mess? Trends Neurosci. 22, 419-422 (1999).
107. Colbourne, F., Sutherland, G. R. & Auer, R. N. Electron microscopic evidence against apoptosis as the mechanism of neuronal death in global ischemia. J. Neurosci. 19, 4200-4210 (1999).
108. Pennacchio, L. A. et al. Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice. Nature Genet 20, 251-258 (1998).
109. Sagot, Y. et al. Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease. J. Neurosci. 15, 7727-7733 (1995).
110. Wellington, C. L. & Hayden, M. R. Caspases and neurodegeneration: on the cutting edge of new therapeutic approaches. Clin. Genet. 57, 1-10 (2000).
111. Bergsmedh, A. et al. Horizontal transfer of oncogenes by uptake of apoptotic bodies. Proc. Natl Acad. Sci. USA 98, 6407-6411 (2001).
112. Boise, L. H. & Collins, C. M. Salmonella-induced cell death: apoptosis, necrosis or programmed cell death? Trends Microbiol. 9, 64-67 (2001).
113. Hentze, H. et al. In vivo and in vitro evidence for extracellular caspase activity released from apoptotic cells. Biochem. Biophys. Res. Commun. 283, 1111-1117 (2001).
114. Torriglia, A. et al. A caspase-independent cell clearance program. The LEI/L-DNase II pathway. Ann. NY Acad. Sci. 926, 192-203 (2000).